Developing new drug combinations to combat drug resistance
Discovery and development of drug cocktails evolved by Nature
This study is looking at how to combine different medicines to fight infections that are becoming harder to treat, using natural substances from microbes to create better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11072003 on NIH RePORTER |
What this research studies
This research focuses on creating effective drug combinations to tackle the growing problem of drug resistance in microbes. By studying how natural products produced by microbes can work together, the research aims to design better treatment options that maximize the effectiveness of existing drugs. The approach involves understanding the mechanisms of action of these drugs and utilizing the natural evolutionary strategies of microbes to develop synergistic combinations. Patients may benefit from improved therapies that are more effective against resistant infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections that are resistant to standard treatments.
Not a fit: Patients with infections that are not drug-resistant may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for infections caused by drug-resistant microbes.
How similar studies have performed: Other research has shown promise in using natural product combinations to enhance drug efficacy, indicating potential success for this approach.
Where this research is happening
College Station, United States
- Texas Engineering Experiment Station — College Station, United States (Active)
Researchers
- Principal investigator: Zhu, Xuejun — Texas Engineering Experiment Station
- Study coordinator: Zhu, Xuejun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.